These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1312183

  • 1. [Evaluation of proposed criteria of disk susceptibility testing for tosufloxacin and lomefloxacin in NCCLS guidelines and WHO standards].
    Aihara M, Oguri T, Kanno H, Kubo S, Honda M, Satoh K, Daimon Y, Yamanaka K, Sugawara K, Furuta T.
    Rinsho Byori; 1992 Jan; 40(1):73-80. PubMed ID: 1312183
    [Abstract] [Full Text] [Related]

  • 2. Interpretive criteria for CI-960 (AM-1091, PD127391) disk diffusion tests using 5-microgram disks.
    Jones RN, Erwin ME, Barrett MS.
    Diagn Microbiol Infect Dis; 1992 Jan; 15(4):379-81. PubMed ID: 1319303
    [Abstract] [Full Text] [Related]

  • 3. Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium.
    Erwin ME, Jones RN.
    J Clin Microbiol; 1992 May; 30(5):1170-3. PubMed ID: 1316366
    [Abstract] [Full Text] [Related]

  • 4. Multi-center validation of proposed disk diffusion susceptibility testing interpretive criteria for lomefloxacin using more than 1,500 clinical isolates.
    Cormican MG, Erwin MS, Jones RN.
    Diagn Microbiol Infect Dis; 1996 Mar; 24(3):169-72. PubMed ID: 8724404
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
    Fuchs PC, Barry AL, Jones RN, Thornsberry C, Ayers LW, Gavan TL, Gerlach EH.
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):185-92. PubMed ID: 3471371
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection of quinolone-resistant Neisseria gonorrhoeae.
    Kam KM, Wong PW, Cheung MM, Ho NK.
    J Clin Microbiol; 1996 Jun; 34(6):1462-4. PubMed ID: 8735098
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium.
    Pfaller MA, Jones RN, Washington JA, Koontz FP, Gerlach EH, Erwin ME.
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2):145-50. PubMed ID: 1315231
    [Abstract] [Full Text] [Related]

  • 19. Temafloxacin disk potency and tentative interpretive criteria for susceptibility tests.
    Barry AL, Jones RN.
    J Clin Microbiol; 1989 Dec; 27(12):2861-3. PubMed ID: 2592548
    [Abstract] [Full Text] [Related]

  • 20. Interpretive criteria for DU-6859a disk diffusion tests using 5-micrograms disks.
    Jones RN, Johnson DM, Erwin ME.
    Diagn Microbiol Infect Dis; 1994 Feb; 18(2):125-7. PubMed ID: 8062531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.